0SX

8-chloro-2-[(2S)-pyrrolidin-2-yl][1]benzofuro[3,2-d]pyrimidin-4(3H)-one

Created:	2012-05-24
Last modified:	2012-10-26

Find Related PDB Entry
2 entries where 0SX is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	32
Chiral Atom Count	1
Bond Count	35
Aromatic Bond Count	10

2D diagram of 0SX

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	8-chloro-2-[(2S)-pyrrolidin-2-yl][1]benzofuro[3,2-d]pyrimidin-4(3H)-one
Systematic Name (OpenEye OEToolkits)	8-chloranyl-2-[(2S)-pyrrolidin-2-yl]-3H-[1]benzofuro[3,2-d]pyrimidin-4-one
Formula	C₁₄ H₁₂ Cl N₃ O₂
Molecular Weight	289.717
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	Clc4cc3c(oc1c3N=C(NC1=O)C2NCCC2)cc4
SMILES	CACTVS	3.370	Clc1ccc2oc3C(=O)NC(=Nc3c2c1)[CH]4CCCN4
SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1Cl)c3c(o2)C(=O)NC(=N3)C4CCCN4
Canonical SMILES	CACTVS	3.370	Clc1ccc2oc3C(=O)NC(=Nc3c2c1)[C@@H]4CCCN4
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1cc2c(cc1Cl)c3c(o2)C(=O)NC(=N3)[C@@H]4CCCN4
InChI	InChI	1.03	InChI=1S/C14H12ClN3O2/c15-7-3-4-10-8(6-7)11-12(20-10)14(19)18-13(17-11)9-2-1-5-16-9/h3-4,6,9,16H,1-2,5H2,(H,17,18,19)/t9-/m0/s1
InChIKey	InChI	1.03	JJWLXRKVUJDJKG-VIFPVBQESA-N

Drug Info: DrugBank

DrugBank ID	DB12357
Name	BMS-863233
Groups	investigational
Description	BMS-863233 has been investigated for the treatment of Refractory Hematologic Cancer.
Synonyms	BMS-863233 BMS-863233 hydrochloride
CAS number	1169558-38-6

Related Resource References

Resource Name	Reference
Pharos	CHEMBL2030402
PubChem	57899889, 135564632
ChEMBL	CHEMBL2030402

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.